- Molecular NameBenzyl Benzoate
- SynonymNA
- Weight212.248
- Drugbank_IDDB00676
- ACS_NO120-51-4
- Show 3D model
- LogP (experiment)3.97
- LogP (predicted, AB/LogP v2.0)3.59
- pkaN/A
- LogD (pH=7, predicted)3.59
- Solubility (experiment)Insoluble
- LogS (predicted, ACD/Labs)(ph=7)-3.45
- LogSw (predicted, AB/LogsW2.0)0.04
- Sw (mg/ml) (predicted, ACD/Labs)0.08
- No.of HBond Donors0
- No.of HBond Acceptors2
- No.of Rotatable Bonds4
- TPSA26.3
- StatusFDA approved
- AdministrationN/A
- PharmacologyBenzyl benzoate, as a topical solution, may be used as an antiparasitic insecticide to kill the mites responsible for the skin condition scabies.
- Absorption_valueN/A
- Absorption (description)N/A
- Caco_2N/A
- BioavailabilityN/A
- Protein bindingN/A
- Volume of distribution (VD)N/A
- Blood/Plasma Partitioning ratio (D_blood)N/A
- MetabollsmRapidly hydrolysed to benzoic acid and benzyl alcohol; benzyl alcohol then undergoes further oxidation to benzoic acid followed by conjugation with glycine to form hippuric acid.
- Half lifeN/A
- ExcretionExcreted in the urine mainly as hippuric acid.
- Urinary ExcretionN/A
- CleranceN/A
- ToxicityOral, rabbit: LD50 = 1680 mg/kg; Skin, rabbit: LD50 = 4000 mg/kg. Symptoms of overdose include blister formation, crusting, itching, oozing, reddening, or scaling of skin; difficulty in urinating (dribbling); jerking movements; sudden loss of consciousness.
- LD50 (rat)N/A
- LD50 (mouse)N/A